Literature DB >> 30074538

Data Mining for Adverse Drug Events With a Propensity Score-matched Tree-based Scan Statistic.

Shirley V Wang1, Judith C Maro2, Elande Baro3, Rima Izem3, Inna Dashevsky2, James R Rogers1, Michael Nguyen4, Joshua J Gagne1, Elisabetta Patorno1, Krista F Huybrechts1, Jacqueline M Major4, Esther Zhou4, Megan Reidy2, Austin Cosgrove2, Sebastian Schneeweiss1, Martin Kulldorff1.   

Abstract

The tree-based scan statistic is a statistical data mining tool that has been used for signal detection with a self-controlled design in vaccine safety studies. This disproportionality statistic adjusts for multiple testing in evaluation of thousands of potential adverse events. However, many drug safety questions are not well suited for self-controlled analysis. We propose a method that combines tree-based scan statistics with propensity score-matched analysis of new initiator cohorts, a robust design for investigations of drug safety. We conducted plasmode simulations to evaluate performance. In multiple realistic scenarios, tree-based scan statistics in cohorts that were propensity score matched to adjust for confounding outperformed tree-based scan statistics in unmatched cohorts. In scenarios where confounding moved point estimates away from the null, adjusted analyses recovered the prespecified type 1 error while unadjusted analyses inflated type 1 error. In scenarios where confounding moved point estimates toward the null, adjusted analyses preserved power, whereas unadjusted analyses greatly reduced power. Although complete adjustment of true confounders had the best performance, matching on a moderately mis-specified propensity score substantially improved type 1 error and power compared with no adjustment. When there was true elevation in risk of an adverse event, there were often co-occurring signals for clinically related concepts. TreeScan with propensity score matching shows promise as a method for screening and prioritization of potential adverse events. It should be followed by clinical review and safety studies specifically designed to quantify the magnitude of effect, with confounding control targeted to the outcome of interest.

Entities:  

Mesh:

Year:  2018        PMID: 30074538      PMCID: PMC6167151          DOI: 10.1097/EDE.0000000000000907

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  27 in total

1.  A data mining approach for signal detection and analysis.

Authors:  Andrew Bate; Marie Lindquist; I Ralph Edwards; Roland Orre
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Multiple comparisons? No problem!

Authors:  C Poole
Journal:  Epidemiology       Date:  1991-07       Impact factor: 4.822

3.  Managing drug-risk information--what to do with all those new numbers.

Authors:  Jerry Avorn; Sebastian Schneeweiss
Journal:  N Engl J Med       Date:  2009-07-27       Impact factor: 91.245

4.  Likelihood ratio based tests for longitudinal drug safety data.

Authors:  Lan Huang; Jyoti Zalkikar; Ram Tiwari
Journal:  Stat Med       Date:  2014-02-09       Impact factor: 2.373

5.  Future cases as present controls to adjust for exposure trend bias in case-only studies.

Authors:  Shirley Wang; Crystal Linkletter; Malcolm Maclure; David Dore; Vincent Mor; Stephen Buka; Gregory A Wellenius
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

6.  A combined comorbidity score predicted mortality in elderly patients better than existing scores.

Authors:  Joshua J Gagne; Robert J Glynn; Jerry Avorn; Raisa Levin; Sebastian Schneeweiss
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

7.  Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures.

Authors:  Pei San Ang; Zhaojin Chen; Cheng Leng Chan; Bee Choo Tai
Journal:  Expert Opin Drug Saf       Date:  2016-04-07       Impact factor: 4.250

Review 8.  Novel data-mining methodologies for adverse drug event discovery and analysis.

Authors:  R Harpaz; W DuMouchel; N H Shah; D Madigan; P Ryan; C Friedman
Journal:  Clin Pharmacol Ther       Date:  2012-06       Impact factor: 6.875

9.  Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.

Authors:  Meijia Zhou; Shirley V Wang; Charles E Leonard; Joshua J Gagne; Candace Fuller; Christian Hampp; Patrick Archdeacon; Sengwee Toh; Aarthi Iyer; Tiffany Siu Woodworth; Elizabeth Cavagnaro; Catherine A Panozzo; Sophia Axtman; Ryan M Carnahan; Elizabeth A Chrischilles; Sean Hennessy
Journal:  Epidemiology       Date:  2017-11       Impact factor: 4.822

Review 10.  Measuring frailty using claims data for pharmacoepidemiologic studies of mortality in older adults: evidence and recommendations.

Authors:  Dae Hyun Kim; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-06-24       Impact factor: 2.890

View more
  8 in total

Review 1.  Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care.

Authors:  Sruthi Adimadhyam; Erin F Barreto; Noelle M Cocoros; Sengwee Toh; Jeffrey S Brown; Judith C Maro; Jacqueline Corrigan-Curay; Gerald J Dal Pan; Robert Ball; David Martin; Michael Nguyen; Richard Platt; Xiaojuan Li
Journal:  J Am Soc Nephrol       Date:  2020-10-19       Impact factor: 10.121

2.  An Implementation and Visualization of the Tree-Based Scan Statistic for Safety Event Monitoring in Longitudinal Electronic Health Data.

Authors:  Stephen E Schachterle; Sharon Hurley; Qing Liu; Kenneth R Petronis; Andrew Bate
Journal:  Drug Saf       Date:  2019-06       Impact factor: 5.606

Review 3.  Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and Considerations.

Authors:  Jenna Wong; Daniel Prieto-Alhambra; Peter R Rijnbeek; Rishi J Desai; Jenna M Reps; Sengwee Toh
Journal:  Drug Saf       Date:  2022-05-17       Impact factor: 5.228

4.  Analyzing adverse drug reaction using statistical and machine learning methods: A systematic review.

Authors:  Hae Reong Kim; MinDong Sung; Ji Ae Park; Kyeongseob Jeong; Ho Heon Kim; Suehyun Lee; Yu Rang Park
Journal:  Medicine (Baltimore)       Date:  2022-06-24       Impact factor: 1.817

Review 5.  Broadening the reach of the FDA Sentinel system: A roadmap for integrating electronic health record data in a causal analysis framework.

Authors:  Rishi J Desai; Michael E Matheny; Kevin Johnson; Keith Marsolo; Lesley H Curtis; Jennifer C Nelson; Patrick J Heagerty; Judith Maro; Jeffery Brown; Sengwee Toh; Michael Nguyen; Robert Ball; Gerald Dal Pan; Shirley V Wang; Joshua J Gagne; Sebastian Schneeweiss
Journal:  NPJ Digit Med       Date:  2021-12-20

6.  Signal Detection of Adverse Events Associated with Trastuzumab in a Cohort of Elderly Patients with Breast Cancer.

Authors:  Efstathia Polychronopoulou; Sharon H Giordano; Lin-Na Chou; Xiaoying Yu; Yong-Fang Kuo
Journal:  Oncologist       Date:  2022-06-08       Impact factor: 5.837

7.  A tree-based scan statistic for zero-inflated count data in post-market drug safety surveillance.

Authors:  Goeun Park; Inkyung Jung
Journal:  Sci Rep       Date:  2022-09-29       Impact factor: 4.996

8.  A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes.

Authors:  Michael Fralick; Martin Kulldorff; Donald Redelmeier; Shirley V Wang; Seanna Vine; Sebastian Schneeweiss; Elisabetta Patorno
Journal:  Endocrinol Diabetes Metab       Date:  2021-04-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.